Alpha-Gal Syndrome PBMC
About: Alpha-Gal Syndrome PBMC samples are collected from clinically confirmed Alpha-Gal Syndrome donors and cryopreserved for downstream immunology and inflammatory research. Ideal for studying inflammatory pathways, immune cell responses, and therapeutic development in Alpha-Gal Syndrome.
| Lot # | Condition | Cell Count (M) | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 68262 | Alpha-Gal Syndrome (AGS) | 10M | Caucasian | 23 | Female | United States (US) |
zoely birth control albuterol, PRN vitamin D supplement iron supplement
|
10 | $530.00 | |
| 66639 | Alpha-Gal Syndrome (AGS) | 10M | Caucasian | 55 | Male | United States (US) |
B12/QOD Magnesium/QOD Zinc/QOD Potassium Citrate Vitamin C/QOD Lions mane/QOD
|
2 | $530.00 | |
| 66675 | Alpha-Gal Syndrome (AGS) | 10M | Caucasian | 67 | Male | United States (US) |
Klonidine 0.1 mg QD Valsartan/HCTZ 80/25 mg QD Atorvastatin 40 mg QD Metoprolol 100 mg QD
|
8 | $530.00 | |
| 66839 | Alpha-Gal Syndrome (AGS) | 10M | Caucasian | 34 | Male | United States (US) |
Sertraline 50 mg QD Zyrtec 20 mg BID Epi Pen PRN Pepcid 20 mg BID Singulair 10 mg QD Ativan 0.5 mg PRN
|
4 | $530.00 | |
| 66721 | Alpha-Gal Syndrome (AGS) | 10M | Caucasian | 44 | Female | United States (US) | 3 | $530.00 |
High-Quality Alpha-Gal Syndrome PBMC for Research
Human Alpha-Gal Syndrome PBMC products are sourced from donors clinically diagnosed with Alpha-Gal Syndrome and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies on immune dysregulation, cytokine response, and therapeutic screening for Alpha-Gal Syndrome-related inflammation.
Product Features
- Research Use Only (RUO), cryopreserved PBMCs
- Clinically confirmed Alpha-Gal Syndrome donors
- Available in cell counts ranging from 5 million to 2 billion
- Processed within 24 hours of collection
- Stored using CryoStor® CS10 freezing media
- IRB-approved protocols and electronic informed consent
- Screen LeukoLot™ available prior to bulk orders
De-identified Donor Data
- Verified Alpha-Gal Syndrome diagnosis
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Self-reported allergies and infectious disease history
- Additional Alpha-Gal Syndrome-specific data available upon request
Applications
- Biomarker discovery and validation
- Drug screening and therapeutic development
- Immune pathway analysis in Alpha-Gal Syndrome pathophysiology
- Transcriptomic and proteomic profiling
Quality and Compliance
- IRB-approved collections and protocols
- 21 CFR Part 11 – compliant e-consent system
- HIPAA-compliant donor data protection
Ordering & Shipping
Alpha-Gal Syndrome PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact learnmore@sanguinebio.com to confirm documentation and compliance needs.
Protocols & Documentation
-
Download
PBMC Isolation from Whole Blood
Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Download
Thawing Cryopreserved PBMC
Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
PBMC
Frequently Asked Questions
1 Answer
Electronic medical records are an option to be included with the PBMC sample, as well as, flow cytometry and other phenotypic testing.
1 Answer
YES – we can often accommodate treatment-naive samples including various cancers, and you can specify immunosupression status or other requirements in the I/E criteria.
1 Answer
Self-reported infectious disease testing is always available and some of our products have additional testing.
1 Answer
HLA-typing is available for some of our PBMC products.
1 Answer
YES to both – Unique donors can be specified, and multiple vials from the same donor can be arranged. You can specify these requirements when ordering.
1 Answer
Healthy PBMCs achieve over 90% vialbity post-thaw. Although our disease-state PBMCs are processed with same stringent SOP, there is more variability depending upon disease. Learn more about our post thaw viability here. https://sanguinebio.com/pbmc-viability-quality-assurance/
Ask a Question
Need a custom PBMC cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.